Researchers from UCSF and the Technical University of Munich (TUM) have developed engineered regulatory immune cells to precisely modulate the im ...

Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...

A $29 entry price helps provide accessibility for people pursuing weight loss goalsService includes all features of Noom Med ...

Progeria Studies: Investigating Telomir-1's effects on telomere stability and accelerated aging in human cell lines and nematode models. Type 2 Diabetes: Further validating Telomir-1's ability to ...

Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 (Grb2) as Fundamental Link in Insulin ResistanceReallocates ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...

To test their guards in a living organism, the researchers then took beta cells derived from stem cells and implanted them ...

Scientists created a fetal pancreas organoid with all key cell types and identified a unique stem cell. This may lead to ...

A new technology uses engineered T cells that act as immune “referees” to soothe overreacting immune responses. They also can ...

Telomir Pharmaceuticals unveils preclinical data on Telomir-1, highlighting its potential in Type 2 diabetes, aging, and inflammatory diseases.

MIAMI, FL / / December 3, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), an emerging leader in age-reversal science, today announced groundbreaking preclinical ...